Hsa_Circ_0001206 is downregulated and inhibits cell proliferation, migration and invasion in prostate cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Crawford ED, Black L, Eaddy M, et al. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Prostate Cancer Prostatic Dis. 2010;13:162–167.
   PubMed Web of Science ®Google Scholar
• Sternberg CN. Novel hormonal therapy for castration-resistant prostate cancer. Ann Oncol. 2012; 23:x259–263.
   PubMed Web of Science ®Google Scholar
• Hayes JH, Barry MJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA. 2014;311:1143–1149.
   PubMed Web of Science ®Google Scholar
• Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101:374–383.
   PubMedGoogle Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12:381–388.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–388.
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–338.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Bao C, Guo W, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7:11215.
   PubMed Web of Science ®Google Scholar
• Memczak S, Papavasileiou P, Peters O, et al. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood. PLoS One. 2015;10:e0141214.
   PubMed Web of Science ®Google Scholar
• Bahn JH, Zhang Q, Li F, et al. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2015;61:221–230.
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang L, Fan K, et al. Circular RNA-ITCH suppresses lung cancer proliferation via inhibiting the Wnt/β-catenin pathway. Biomed Res Int. 2016;2016:1579490.
   PubMed Web of Science ®Google Scholar
• Li P, Chen H, Chen S, et al. Circular RNA 0000096 affects cell growth and migration in gastric cancer. Br J Cancer. 2017;116:626–633.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao X, Zhang M, et al. Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis. J Natl Cancer Inst. 2018;110(3)
   Google Scholar
• Zhong Z, Huang M, Lv M, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 2017;403:305–317.
   PubMed Web of Science ®Google Scholar
• Yang Z, Qu CB, Zhang Y, et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene. 2018;38(14):2516–2532.
   Web of Science ®Google Scholar
• Chen S, Huang V, Xu X, et al. Widespread and functional RNA circularization in localized prostate cancer. Cell 2019;176:831–843 e22.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;345:W98–W102.
   Web of Science ®Google Scholar
• Lee T, Paquet M, Larsson O, et al. Tumor cell survival dependence on the DHX9 DExH-box helicase. Oncogene. 2016;35:5093–5105.
   PubMed Web of Science ®Google Scholar
• Wang K, Sun Y, Tao W, et al. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett. 2017;394:1–12.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng F, Xiao X, et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep. 2017;18:1646–1659.
   PubMed Web of Science ®Google Scholar
• Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66:1151–1164.
   PubMed Web of Science ®Google Scholar
• Liu Y, Dong Y, Zhao L, et al. Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis. Int J Oncol. 2018;53:1752–1762.
   PubMed Web of Science ®Google Scholar
• Si-Tu J, Cai Y, Feng T, et al. Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer. Int J Biol Macromol. 2019;122:1235–1243.
   PubMed Web of Science ®Google Scholar
• Boyle S, Gilchrist S, Bridger JM, et al. The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. Hum Mol Genet. 2001;10:211–219.
   PubMed Web of Science ®Google Scholar
• Rubicz R, Zhao S, April C, et al. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort. Prostate. 2015;75:1354–1362.
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56:55–66.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang C, Qi S, et al. Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress. Oncotarget 2016;7:84893–84906.
   PubMedGoogle Scholar
• Ready D, Yagiz K, Amin P, et al. Mapping the STK4/Hippo signaling network in prostate cancer cell. PLoS One. 2017;12:e0184590.
   PubMed Web of Science ®Google Scholar
• Reebye V, Bevan CL, Nohadani M, et al. Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer. Cell Signal. 2010;22:1874–1881.
   PubMed Web of Science ®Google Scholar
• Birk E, Har-Zahav A, Manzini CM, et al. SOBP is mutated in syndromic and nonsyndromic intellectual disability and is highly expressed in the brain limbic system. Am J Hum Genet. 2010;87:694–700.
   PubMed Web of Science ®Google Scholar
• Kahl P, Gullotti L, Heukamp LC, et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 2006;66:11341–11347.
   PubMed Web of Science ®Google Scholar
• Wang M, Liu X, Jiang G, et al. Relationship between LSD1 expression and E-cadherin expression in prostate cancer. Int Urol Nephrol. 2015;47:485–490.
   PubMed Web of Science ®Google Scholar
• Kashyap V, Ahmad S, Nilsson EM, et al. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol. 2013;7:555–566.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhang Z, Zheng P, et al. MicroRNA-1285-5p influences the proliferation and metastasis of non-small-cell lung carcinoma cells via downregulating CDH1 and Smad4. Tumour Biol. 2017;39:1010428317705513.
   Google Scholar
• Hironaka-Mitsuhashi A, Matsuzaki J, Takahashi RU, et al. A tissue microRNA signature that predicts the prognosis of breast cancer in young women. PLoS One. 2017;12:e0187638.
   PubMed Web of Science ®Google Scholar
• Borrelli N, Denaro M, Ugolini C, et al. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas. Mod Pathol. 2017;30:39–51.
   PubMed Web of Science ®Google Scholar
• Ding Z, Wu CJ, Chu GC, et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature. 2011;470:269–273.
   PubMed Web of Science ®Google Scholar
• Horvath LG, Henshall SM, Kench JG, et al. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate. 2004;59:234–242.
   PubMed Web of Science ®Google Scholar
• Cao S, Sun R, Wang W, et al. RNA helicase DHX9 may be a therapeutic target in lung cancer and inhibited by enoxacin. Am J Transl Res. 2017;9:674–682.
   PubMed Web of Science ®Google Scholar
• Han J, Meng J, Chen S, et al. YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 2019;79:1451–1464.
   PubMed Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125–1134.
   PubMed Web of Science ®Google Scholar
• Lee T, Pelletier J. The biology of DHX9 and its potential as a therapeutic target. Oncotarget. 2016;7:42716–42739.
   PubMedGoogle Scholar
• Schlegel BP, Starita LM, Parvin JD. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene. 2003;22:983–991.
   PubMed Web of Science ®Google Scholar
• Mi J, Ray P, Liu J, et al. In vivo selection against human colorectal cancer xenografts identifies an aptamer that targets RNA helicase protein DHX9. Mol Ther Nucleic Acids. 2016;5:e315.
   PubMedGoogle Scholar
• Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68:1214–1227.
   PubMed Web of Science ®Google Scholar
• Fidaleo M, Svetoni F, Volpe E, et al. Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9. Oncotarget. 2015;6:31740–31757.
   PubMedGoogle Scholar
• Kong Z, Wan X, Zhang Y, et al. Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer. Biochem Biophys Res Commun. 2017;493:1217–1223.
   PubMed Web of Science ®Google Scholar